Skip Navigation
Skip to contents

Diabetes Metab J : Diabetes & Metabolism Journal

Search
OPEN ACCESS

Author index

Page Path
HOME > Browse > Author index
Search
Sung Gyun Ahn  (Ahn SG) 1 Article
Obesity and Metabolic Syndrome
Impact of Longitudinal Changes in Metabolic Syndrome Status over 2 Years on 10-Year Incident Diabetes Mellitus
Ji Hye Huh, Sung Gyun Ahn, Young In Kim, Taehwa Go, Ki-Chul Sung, Jae Hyuk Choi, Kwang Kon Koh, Jang Young Kim
Diabetes Metab J. 2019;43(4):530-538.   Published online February 20, 2019
DOI: https://doi.org/10.4093/dmj.2018.0111
  • 6,016 View
  • 67 Download
  • 21 Web of Science
  • 23 Crossref
AbstractAbstract PDFPubReader   
Background

Metabolic syndrome (MetS) is a known predictor of diabetes mellitus (DM), but whether longitudinal changes in MetS status modify the risk for DM remains unclear. We investigated whether changes in MetS status over 2 years modify the 10-year risk of incident DM.

Methods

We analyzed data from 7,317 participants aged 40 to 70 years without DM at baseline, who took part in 2001 to 2011 Korean Genome Epidemiology Study. Subjects were categorized into four groups based on repeated longitudinal assessment of MetS status over 2 years: non-MetS, resolved MetS, incident MetS, and persistent MetS. The hazard ratio (HR) of new-onset DM during 10 years was calculated in each group using Cox models.

Results

During the 10-year follow-up, 1,099 participants (15.0%) developed DM. Compared to the non-MetS group, the fully adjusted HRs for new-onset DM were 1.28 (95% confidence interval [CI], 0.92 to 1.79) in the resolved MetS group, 1.75 (95% CI, 1.30 to 2.37) in the incident MetS group, and 1.98 (95% CI, 1.50 to 2.61) in the persistent MetS group (P for trend <0.001). The risk of DM in subjects with resolved MetS was significantly attenuated compared to those with persistent MetS over 2 years. In addition, the adjusted HR for 10-year developing DM gradually increased as the number of MetS components increased 2 years later.

Conclusion

We found that discrete longitudinal changes pattern in MetS status over 2 years associated with 10-year risk of DM. These findings suggest that monitoring change of MetS status and controlling it in individuals may be important for risk prediction of DM.

Citations

Citations to this article as recorded by  
  • 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association
    Seth S. Martin, Aaron W. Aday, Zaid I. Almarzooq, Cheryl A.M. Anderson, Pankaj Arora, Christy L. Avery, Carissa M. Baker-Smith, Bethany Barone Gibbs, Andrea Z. Beaton, Amelia K. Boehme, Yvonne Commodore-Mensah, Maria E. Currie, Mitchell S.V. Elkind, Kelly
    Circulation.2024;[Epub]     CrossRef
  • Transitioning from having no metabolic abnormality nor obesity to metabolic impairment in a cohort of apparently healthy adults
    Hadas Ben-Assayag, Rafael Y. Brzezinski, Shlomo Berliner, David Zeltser, Itzhak Shapira, Ori Rogowski, Sharon Toker, Roy Eldor, Shani Shenhar-Tsarfaty
    Cardiovascular Diabetology.2023;[Epub]     CrossRef
  • Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
    Connie W. Tsao, Aaron W. Aday, Zaid I. Almarzooq, Cheryl A.M. Anderson, Pankaj Arora, Christy L. Avery, Carissa M. Baker-Smith, Andrea Z. Beaton, Amelia K. Boehme, Alfred E. Buxton, Yvonne Commodore-Mensah, Mitchell S.V. Elkind, Kelly R. Evenson, Chete Ez
    Circulation.2023;[Epub]     CrossRef
  • The Unique Role of Self-Rated Health in Metabolic Syndrome and its Diagnostic Cardiometabolic Abnormalities: An Analysis of Population-Based Data
    K. Umeh, S. Adaji, L. Graham
    Journal of Medical Psychology.2023; 25(1): 7.     CrossRef
  • Gender differences in the impact of 3-year status changes of metabolic syndrome and its components on incident type 2 diabetes mellitus: a decade of follow-up in the Tehran Lipid and Glucose Study
    Farzad Hadaegh, Amir Abdi, Karim Kohansal, Parto Hadaegh, Fereidoun Azizi, Maryam Tohidi
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Clinical implications of changes in metabolic syndrome status after kidney transplantation: a nationwide prospective cohort study
    Yu Ho Lee, Sang Heon Song, Seung Hwan Song, Ho Sik Shin, Jaeseok Yang, Myoung Soo Kim, Hyeon Seok Hwang, Curie Ahn, Jaeseok Yang, Jin Min Kong, Oh Jung Kwon, Deok Gie Kim, Cheol-Woong Jung, Yeong Hoon Kim, Joong Kyung Kim, Chan-Duck Kim, Ji Won Min, Sung
    Nephrology Dialysis Transplantation.2023; 38(12): 2743.     CrossRef
  • Trajectory patterns of metabolic syndrome severity score and risk of type 2 diabetes
    Atieh Amouzegar, Mohammadjavad Honarvar, Safdar Masoumi, Davood Khalili, Fereidoun Azizi, Ladan Mehran
    Journal of Translational Medicine.2023;[Epub]     CrossRef
  • Differential association of metabolic syndrome and low-density lipoprotein cholesterol with incident cardiovascular disease according to sex among Koreans: a national population-based study
    Su Yong Kim, Tae-Hwa Go, Jun Hyeok Lee, Jin Sil Moon, Dae Ryong Kang, Se Jin Bae, Se-Eun Kim, Sang Jun Lee, Dong-Hyuk Cho, Young Jun Park, Young Jin Youn, Jang Young Kim, Sung Gyun Ahn
    European Journal of Preventive Cardiology.2022; 28(18): 2021.     CrossRef
  • The efficacy and safety of Dendropanax morbifera leaf extract on the metabolic syndrome: a 12-week, placebo controlled, double blind, and randomized controlled trial
    Ji Eun Jun, You-Cheol Hwang, Kyu Jeung Ahn, Ho Yeon Chung, Se Young Choung, In-Kyung Jeong
    Nutrition Research and Practice.2022; 16(1): 60.     CrossRef
  • Stability and Transformation of Metabolic Syndrome in Adolescents: A Prospective Assessment in Relation to the Change of Cardiometabolic Risk Factors
    Pei-Wen Wu, Yi-Wen Lai, Yu-Ting Chin, Sharon Tsai, Tun-Min Yang, Wei-Ting Lin, Chun-Ying Lee, Wei-Chung Tsai, Hsiao-Ling Huang, David W. Seal, Tsai-Hui Duh, Chien-Hung Lee
    Nutrients.2022; 14(4): 744.     CrossRef
  • Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association
    Connie W. Tsao, Aaron W. Aday, Zaid I. Almarzooq, Alvaro Alonso, Andrea Z. Beaton, Marcio S. Bittencourt, Amelia K. Boehme, Alfred E. Buxton, April P. Carson, Yvonne Commodore-Mensah, Mitchell S.V. Elkind, Kelly R. Evenson, Chete Eze-Nliam, Jane F. Fergus
    Circulation.2022;[Epub]     CrossRef
  • Evaluating Triglyceride and Glucose Index as a Simple and Easy-to-Calculate Marker for All-Cause and Cardiovascular Mortality
    Kyung-Soo Kim, Sangmo Hong, You-Cheol Hwang, Hong-Yup Ahn, Cheol-Young Park
    Journal of General Internal Medicine.2022; 37(16): 4153.     CrossRef
  • Nonlinear association between changes in fasting plasma glucose and the incidence of diabetes in a nondiabetic Chinese cohort
    Chenghu Huang, Chenhong Ren, Xiuping Xuan, Yi Luo, Caibi Peng
    BMC Endocrine Disorders.2022;[Epub]     CrossRef
  • The dynamics of metabolic syndrome development from its isolated components among iranian children and adolescents: Findings from 17 Years of the Tehran Lipid and Glucose Study (TLGS)
    Pezhman Bagheri, Davood Khalil, Mozhgan Seif, Esmaeil Khedmati Morasae, Ehsan Bahramali, Fereidoun Azizi, Abbas Rezaianzadeh
    Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2021; 15(1): 99.     CrossRef
  • Heart Disease and Stroke Statistics—2021 Update
    Salim S. Virani, Alvaro Alonso, Hugo J. Aparicio, Emelia J. Benjamin, Marcio S. Bittencourt, Clifton W. Callaway, April P. Carson, Alanna M. Chamberlain, Susan Cheng, Francesca N. Delling, Mitchell S.V. Elkind, Kelly R. Evenson, Jane F. Ferguson, Deepak K
    Circulation.2021;[Epub]     CrossRef
  • The dynamics of metabolic syndrome development from its isolated components among Iranian adults: findings from 17 years of the Tehran lipid and glucose study (TLGS)
    Davood Khalili, Pezhman Bagheri, Mozhgan Seif, Abbas Rezaianzadeh, Esmaeil Khedmati Morasae, Ehsan Bahramali, Fereidoun Azizi
    Journal of Diabetes & Metabolic Disorders.2021; 20(1): 95.     CrossRef
  • Metabolic Syndrome Fact Sheet 2021: Executive Report
    Ji Hye Huh, Dae Ryong Kang, Jang Young Kim, Kwang Kon Koh
    CardioMetabolic Syndrome Journal.2021; 1(2): 125.     CrossRef
  • The Incidence of Metabolic Syndrome and the Valid Blood Pressure Cutoff Value for Predicting Metabolic Syndrome Within the Normal Blood Pressure Range in the Population Over 40 Years Old in Guiyang, China
    Li Ma, Hong Li, Huijun Zhuang, Qiao Zhang, Nianchun Peng, Ying Hu, Na Han, Yuxing Yang, Lixin Shi
    Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2021; Volume 14: 2973.     CrossRef
  • Metabolic Syndrome Severity Score for Predicting Cardiovascular Events: A Nationwide Population-Based Study from Korea
    Yo Nam Jang, Jun Hyeok Lee, Jin Sil Moon, Dae Ryong Kang, Seong Yong Park, Jerim Cho, Jang-Young Kim, Ji Hye Huh
    Diabetes & Metabolism Journal.2021; 45(4): 569.     CrossRef
  • Hospitalization for heart failure incidence according to the transition in metabolic health and obesity status: a nationwide population-based study
    You-Bin Lee, Da Hye Kim, Seon Mee Kim, Nan Hee Kim, Kyung Mook Choi, Sei Hyun Baik, Yong Gyu Park, Kyungdo Han, Hye Jin Yoo
    Cardiovascular Diabetology.2020;[Epub]     CrossRef
  • Effects of tea consumption on metabolic syndrome: A systematic review and meta‐analysis of randomized clinical trials
    Wei Liu, Chunpeng Wan, Yingjie Huang, Mingxi Li
    Phytotherapy Research.2020; 34(11): 2857.     CrossRef
  • Exposure-weighted scoring for metabolic syndrome and the risk of myocardial infarction and stroke: a nationwide population-based study
    Eun Young Lee, Kyungdo Han, Da Hye Kim, Yong-Moon Park, Hyuk-Sang Kwon, Kun-Ho Yoon, Mee Kyoung Kim, Seung-Hwan Lee
    Cardiovascular Diabetology.2020;[Epub]     CrossRef
  • Changes in Metabolic Profile Over Time: Impact on the Risk of Diabetes
    Yunjung Cho, Seung-Hwan Lee
    Diabetes & Metabolism Journal.2019; 43(4): 407.     CrossRef

Diabetes Metab J : Diabetes & Metabolism Journal
Close layer
TOP